Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

New agent for treating cocaine dependency in development at RBI

Dec. 22, 1999

Preclinical studies validate Nabi's novel approach to treating and preventing nicotine addiction

Dec. 20, 1999

Novartis reports setbacks and advances in the development of new chelating agents

Dec. 8, 1999

Glaxo Wellcome's Zyban approved in The Netherlands for smoking cessation

Dec. 3, 1999

Neuronal nicotinic acetylcholine receptor ligands in early development at Pfizer

Nov. 30, 1999

Pfizer discloses modulators of cholinergic function for smoking cessation, etc.

Nov. 29, 1999

Development of potential new antiaddictive agent supported by NIDA

Oct. 22, 1999

FDA accepts DigiTAb filing for review

Oct. 15, 1999

Schein to license proprietary chelating compound from SunPharm

Oct. 8, 1999

Carbamazepine for the prevention and treatment of alcohol withdrawal syndrome

Sep. 28, 1999